Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma
This study examined the correlation between FAK expression and the prognosis of HCC. Additionally, we explored the impact of FAK degradation on HCC metastasis through wound healing experiments, transwell invasion experiments, and a xenograft tumor model. The expression of proteins related to epithelial-mesenchymal transition (EMT) was measured to elucidate the underlying mechanisms. The results showed that FAK PROTAC can degrade FAK, inhibit the migration and invasion of HCC cells in vitro, and notably decrease the lung metastasis of HCC in vivo. Increased expression of E-cadherin and decreased expression of vimentin indicated that EMT was inhibited. Consequently, degradation of FAK through FAK PROTAC effectively suppressed liver cancer metastasis, holding significant clinical implications for treating liver cancer and developing innovative anti-neoplastic drugs.PMID:38560575 | PMC:PMC10972732 | DOI:10.32604/or.2024.046231
Source: Oncology Research - Category: Cancer & Oncology Authors: Xinfeng Zhang Shuang Li Meiru Song Yue Chen Liangzheng Chang Zherui Liu Hongyuan Dai Yutao Wang Gangqi Yang Yun Jiang Yinying Lu Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology